Literature DB >> 9705993

Muscarinic IPSPs in rat striatal cholinergic interneurones.

P Calabresi1, D Centonze, A Pisani, G Sancesario, R A North, G Bernardi.   

Abstract

1. Intracellular recordings were made from neurones in slice of rat striatum in vitro. 2. The forty-nine neurones studied were immunoreactive for choline acetyltransferase and had the electrophysiological characteristics typical of large aspiny interneurones. 3. Focal stimulation of the slice elicited a hyperpolarizing inhibitory postsynaptic potential in thirty-five neurones. This IPSP lasted 0.5-1 s and reversed polarity at a membrane potential which was dependent on the logarithm of the extracellular potassium concentration. 4. The IPSP was reversibly blocked by scopolamine and methoctramine, which has some selectivity for M2 subtype of muscarinic receptor. It was unaffected by 6-cyano-7-nitroquinoxaline-2,3-dione (10 microM), DL-2-amino-phosphonovaleric acid (30 microM) and bicuculline (30 microM). 5. Exogenous acetylcholine and muscarine also hyperpolarized the neurones, and this was blocked by methoctramine by not by pirenzepine, which is an M1 receptor-selective antagonist. 6. The findings demonstrate that muscarinic IPSPs occur in the central nervous system. The IPSP may mediate an 'autoinhibition' of striatal cholinergic neurone activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705993      PMCID: PMC2231046          DOI: 10.1111/j.1469-7793.1998.421bk.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  23 in total

1.  Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain.

Authors:  S Sugita; N Uchimura; Z G Jiang; R A North
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

Authors:  D M Weiner; A I Levey; M R Brann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 3.  Muscarinic receptors--characterization, coupling and function.

Authors:  M P Caulfield
Journal:  Pharmacol Ther       Date:  1993-06       Impact factor: 12.310

4.  Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs.

Authors:  Y Kawaguchi; C J Wilson; P C Emson
Journal:  J Neurophysiol       Date:  1989-11       Impact factor: 2.714

5.  Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies.

Authors:  S M Hersch; C A Gutekunst; H D Rees; C J Heilman; A I Levey
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

6.  Muscarinic receptors modulate N-, P-, and L-type Ca2+ currents in rat striatal neurons through parallel pathways.

Authors:  A R Howe; D J Surmeier
Journal:  J Neurosci       Date:  1995-01       Impact factor: 6.167

Review 7.  The basal ganglia and adaptive motor control.

Authors:  A M Graybiel; T Aosaki; A W Flaherty; M Kimura
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

8.  Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum.

Authors:  Y Kawaguchi
Journal:  J Neurosci       Date:  1993-11       Impact factor: 6.167

9.  Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum.

Authors:  C J Wilson; H T Chang; S T Kitai
Journal:  J Neurosci       Date:  1990-02       Impact factor: 6.167

10.  Membrane properties and synaptic responses of rat striatal neurones in vitro.

Authors:  Z G Jiang; R A North
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

View more
  37 in total

1.  Spontaneous activity of neostriatal cholinergic interneurons in vitro.

Authors:  B D Bennett; C J Wilson
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

2.  Muscarinic activation of inwardly rectifying K(+) conductance reduces EPSPs in rat hippocampal CA1 pyramidal cells.

Authors:  T Seeger; C Alzheimer
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

Review 3.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

4.  Burst generation mediated by cholinergic input in terminal nerve-gonadotrophin releasing hormone neurones of the goldfish.

Authors:  Takafumi Kawai; Hideki Abe; Yoshitaka Oka
Journal:  J Physiol       Date:  2013-08-19       Impact factor: 5.182

Review 5.  Primary dystonia: molecules and mechanisms.

Authors:  Lauren M Tanabe; Connie E Kim; Noga Alagem; William T Dauer
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

6.  Cholinergic control of excitability of spinal motoneurones in the salamander.

Authors:  Stéphanie Chevallier; Frédéric Nagy; Jean-Marie Cabelguen
Journal:  J Physiol       Date:  2005-11-24       Impact factor: 5.182

Review 7.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

8.  Thalamic gating of corticostriatal signaling by cholinergic interneurons.

Authors:  Jun B Ding; Jaime N Guzman; Jayms D Peterson; Joshua A Goldberg; D James Surmeier
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

9.  GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen.

Authors:  Kalynda Kari Gonzales; Jean-Francois Pare; Thomas Wichmann; Yoland Smith
Journal:  J Comp Neurol       Date:  2013-08-01       Impact factor: 3.215

10.  Nucleus Accumbens Acetylcholine Receptors Modulate Dopamine and Motivation.

Authors:  Anne L Collins; Tara J Aitken; Venuz Y Greenfield; Sean B Ostlund; Kate M Wassum
Journal:  Neuropsychopharmacology       Date:  2016-05-31       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.